GlaxoSmithKline Pharmaceuticals Ltd. Financials

NSE BSE

15:59 Sep 12

GlaxoSmithKline Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2774.00

-89.80 (-3.14%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2774.00

-89.80 (-3.14%)
15:59 Sep 12

Quality

79/100
High Financial Strength

Valuation

34/100
Mid Valuation

Technical

52/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	3278.03	3251.72	3453.71	3749.21	3739.73
Operating Expenses +	2516.14	2447.44	2545.02	2571.85	2541.71
Raw Material	1340.62	1215.92	1398.25	1345.01	1394.16
Increase Decrease in Cost	15.57	68.96	-63.72	45.85	-10.86
Other Manufacturing Expense	0	73.85	0	0	0
Employee Cost	610.23	594.99	624.39	579.7	580.99
Miscellaneous Expenses	2008.6	2070.58	2292.26	2291.51	577.42
Operating Profit	761.89	804.28	908.69	1177.36	1198.02
Other Income	75.78	100.66	122.59	145.93	154.01
Depreciation	68.19	65.77	69.68	66.79	65.9
Interest	2	1.81	1.8	1.31	1.36
Profit before tax and exceptio..	767.47	837.37	959.8	1255.19	1284.77
Exceptional Items	11.58	-0.97	-143.62	4.69	4.69
PBT	779.05	836.4	816.19	1259.88	1280.08
Provision for Taxation	398.28	228.76	226.23	332.3	339.2
Net Profit	1694.72	610.69	589.96	927.58	950.26
NET Profit after MI	1694.72	616.72	594.13	930.24	950.26
EPS	100.04	36.05	41.14	54.76	56.1
Operating Profit Margin (%)	23.24	24.73	26.31	31.4	32.03
Net Profit Margin (%)	51.7	18.97	17.2	24.81	25.41

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	75.00	75.00	75.00	75.00	75.00
FII	4.90	4.50	4.50	4.40	4.00
MF	5.20	5.20	5.00	5.00	4.70
Others	2.50	2.60	2.30	2.30	2.80

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: